Educational content on VJNeurology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ESOC 2022 | Biomarkers in thrombotic and embolic stroke

Ana Catarina Fonseca, MD, PhD, University of Lisbon, Lisbon, Portugal, discusses recent updates on biomarkers associated with carotid artery atheroma and cardioembolic stroke. New evidence has demonstrated that interleukin-6 (IL-6) levels are related to prognosis and risk of recurrence in patients with carotid artery atheroma. N-terminal pro-B-type natriuretic peptide (NT-proBNP) remains the most widely studied biomarker in cardioembolic stroke. This interview took place at European Stroke Organisation Conference 2022 in Lyon, France.

Choose your cookie settings

VJNeurology uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.